The booster being the same formula does not, in any respect, mean that. There are quite a few vaccines that are given in multiple similar or identical doses and provide stronger and longer lasting protection after the later sides.
My guess (purely a guess) is that the actual problem with the Pfizer vaccine is that the sides are too close together. The Moderna doses are spaced farther apart and (preliminary, unreviewed) results suggest that it works just fine even six months after the second dose.
I would not be at all surprised if a booster dose of either mRNA vaccine after six months gives essentially lifelong protection. I also would not be surprised if it didn’t.
Early indicators from Israel, which is ahead of the booster curve:
> Israel Is Preparing for Possible Fourth Covid Vaccine Dose
> “We don’t know when it will happen; I hope very much that it won’t be within six months, like this time, and that the third dose will last for longer,” Health Ministry Director General Nachman Ash said in an interview with Radio 103FM.
> Israel, which has mainly used the Pfizer Inc.-BioNTech SE vaccine, has so far inoculated about 2.8 million people with a third dose after beginning a drive to administer booster shots in August. Health officials have said the effects of the initial Covid-19 shots weaken five months after inoculation, making boosters necessary.
https://www.bloomberg.com/news/articles/2021-09-12/israel-pr...
Anyway, I’m rambling. In a nutshell, they shouldn’t be thought of as the same technology because well, they’re not.
IPV , OPV, the DTaP vaccines, the pneumococcal conjugate vaccine, and measles are all different technologies. They’re all biologics, though.
https://data.ct.gov/Health-and-Human-Services/COVID-19-DPH-R...
I dug a bit to double-check the hospitalization rate. The Oct 28 report claims (page 7) "18 Times higher risk of being hospitalized with COVID-19". That's a pretty spectacular number, how did they derive it?
1. The report says "One hundred ninety-one patients are currently hospitalized with laboratory-confirmed COVID-19; of these, 134 (70.2%) are not fully vaccinated.".
2. I found the vaccination rate as 67%, using the dashboard at https://data.ct.gov/stories/s/CoVP-COVID-Vaccine-Distributio....
3. I do a little bit of math.
pop_rate = pop_cases / pop_count
pop_cases = pop_case_rate * cases_total
pop_count = pop_count_rate * pop_total
risk = unvax_rate / vax_rate
= (unvax_rate / unvax_count_rate) / (vax_rate / vax_count_rate)
= (70.2 / 33) / (29.8 / 67)
= 4.8x
Your number (5x) is close to what the data indicates compared with what the report claims (18x). Perhaps someone with better fifth grade math skills can riddle me out...Except Delta emerged in India before there was any evolutionary pressure causes by vaccines and the vaccines still work good for Delta.
>Natural immunity looking better every day eh?
Natural immunity is not immune to evolutionary pressure either
And the vaccine *does* provide protection against Delta--you're less likely to get it and if you do get it it generally is less serious. Being vaccinated cuts your death rate 10x.
Natural immunity isn't going to happen, we have seen far too many cases of reinfection with different variants. The more we see the more hopeless the death cult approach looks.
Please post some proof to corroborate any of this. I assume you’re talking about COVID strains here?
>Natural immunity isn’t going to happen, we have seen far too many cases of reinfection with different variants.
Again, source desperately needed here. I’m more than willing to change my take but only with hard data, not sweeping generalizations based on a misunderstanding of how natural immunity works.
https://www.medicalnewstoday.com/articles/delta-variant-what...
https://www.cdc.gov/media/releases/2021/s0806-vaccination-pr...
We see a lot of data from Israel because they made a deal with Pfizer early on to trade early access to vaccine for allowing Pfizer access to anonymized health records about vaccination and infection. Thus they have some of the best data around on the effect of the Pfizer shot on a population scale.